Latest News
Mon, 20 May 2013
Impax Board of Directors Establishes Compliance Committee
Mon, 20 May 2013Impax Laboratories to Present at the UBS Global Healthcare Conference
Fri, 17 May 2013View All
Our Divisions
A balanced business model that consists of a successful generic business and a brand strategy to drive higher long-term growth.
Products and Pipeline
An expanding product portfolio with a significant pipeline that renews with our continuing investment in R&D.
